Alexandre Gapihan’s practice is primarily focused on matters relating to the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and the pharmaceutical industry, including the approval, regulation, promotion, and sale of drugs, medical devices, and dietary supplements. Alexandre excels in assisting clients in navigating the complex legal and regulatory frameworks that impact their business.
Prior to joining Morgan Lewis, Alexandre was an associate at another international law firm. He is a native French speaker and is conversational in Mandarin Chinese.
University of Pennsylvania Law School, 2015, J.D.
University of Pennsylvania, Wharton School of Business, 2015, Certificate of Study in Business Economics and Public Policy
Vassar College, 2008, B.A., International Studies and Economics
District of Columbia
US District Court for the Eastern District of Pennsylvania